Table 2.
Univariate and multivariate analysis for overall survival in FUSCC.
Variables | Univariate Analysis |
Multivariate Analysis |
||||
---|---|---|---|---|---|---|
Hazard ratio | 95% CI | P value | Hazard ratio | 95% CI | P value | |
ITGAE+TIL | 0.379 | 0.237–0.607 | <0.001 | 0.57 | 0.346–0.938 | 0.027 |
Male gender | 1.255 | 0.797–1.976 | 0.328 | |||
Age > 70 | 1.581 | 0.915 -2.734 | 0.101 | |||
TNM stage IV | 5.118 | 3.574–7.330 | <0.001 | 4.097 | 1.739 -9.649 | 0.001 |
T stage, T4 | 10.531 | 2.580–42.981 | 0.001 | 1.632 | 0.983–2.709 | 0.058 |
N stage, N2 | 4.139 | 2.332–7.346 | <0.001 | 0.861 | 0.612–1.212 | 0.391 |
Grade, poor | 1.36 | 0.880–2.103 | 0.166 | |||
M1 stage | 9.06 | 5.735–14.314 | <0.001 | 1.254 | 0.414–3.804 | 0.689 |
Lymph node examined | 0.72 | 0.465–1.114 | 0.14 | |||
Mucinous Adenocarcinoma | 0.865 | 0.316 -2.364 | 0.77 | |||
Perineural invasion | 1.639 | 0.980–2.740 | 0.06 | |||
Vascular invasion | 2.44 | 1.578–3.776 | <0.001 | 1.293 | 0.772–2.164 | 0.329 |
MSI | 0.923 | 0.589–1.444 | 0.725 | |||
CEA >10 ng/ml | 2.705 | 1.713–4.273 | <0.001 | 1.004 | 0.591–1.708 | 0.987 |
TIL indicates tumor infiltrating lymphocytes; MMR indicates mismatch repair; MS, microsatellite; MSS, microsatellite stability; MSI, microsatellite instability; LN, lymph nodes.